Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Vaccine ; 42(8): 2072-2080, 2024 Mar 19.
Artigo em Inglês | MEDLINE | ID: mdl-38423815

RESUMO

Monkeypox (mpox) is a zoonotic disease caused by monkeypox virus (MPXV) of the orthopoxvirus genus. The emergence and global spread of mpox in 2022 was declared as a public health emergency by World Health Organization. This mpox pandemic alarmed us that mpox still threaten global public health. Live vaccines could be used for immunization for this disease with side effects. New alternative vaccines are urgently needed for this re-emerging disease. Specific antibody responses play key roles for protection against MPXV, therefore, vaccines that induce high humoral immunity will be ideal candidates. In the present study, we developed thermostable nanovaccine candidates for mpox by conjugating MPXV antigens with thermostable nanoscafolds. Three MPXV protective antigens, L1, A29, and A33, and the thermostable Aquafex aeolicus lumazine synthase (AaLS), were expressed in E. coli and purified by Ni-NTA methods. The nanovaccines were generated by conjugation of the antigens with AaLS. Thermal stability test results showed that the nanovaccines remained unchanged after one week storage under 37℃ and only partial degradation under 60℃, indicating high thermostability. Very interesting, one dose immunization with the nanovaccine could induce high potent antibody responses, and two dose induced 2-month high titers of antibodes. In vitro virus neutralization test showed that nanovaccine candidates induced significantly higher levels of neutralization antibodies than monomers. These results indicated that the AaLS conjugation nanovaccines of MPXV antigens are highly thermostable in terms of storage and antigenic, being good alternative vaccine candidates for this re-emerging disease.


Assuntos
Terapias Complementares , Mpox , Humanos , Nanovacinas , Escherichia coli , Adjuvantes Imunológicos , Anticorpos , Antígenos Virais , Monkeypox virus
2.
J Pharm Pharmacol ; 73(7): 881-892, 2021 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-33836071

RESUMO

OBJECTIVES: Milletia speciosa Champ (MS), a traditional Chinese medicine, has the abilities of antistress, antifatigue, anti-oxidation and so on. In our previous study, MS was found to antidepression while the underlying mechanism of which needs further elucidation. METHODS: Here, a proton nuclear magnetic resonance (1H-NMR)-based metabonomics combined network pharmacology research approach was performed to investigate the antidepressive mechanism of MS act on mouse with chronic unpredictable mild stress-induced depression. KEY FINDINGS: Results showed that MS could alleviate the ethology of depression (including sucrose preference degree, crossing lattice numbers and stand-up times) and disordered biochemical parameters (5-hydroxytryptamine, norepinephrine and brain-derived neurotrophic factor). Metabonomics study and network pharmacology analysis showed that MS might improve depression through synergistically regulating five targets including Maoa, Maob, Ache, Ido1 and Comt, and three metabolic pathways such as tryptophan metabolism, synthesis of neurotransmitter and phospholipid metabolism. CONCLUSIONS: This study for the first time preliminary clarified the potential antidepressive mechanism of MS and provided theoretical basis for developing MS into novel effective antidepressant.


Assuntos
Transtorno Depressivo , Medicamentos de Ervas Chinesas/farmacologia , Metabolômica/métodos , Millettia , Farmacologia em Rede/métodos , Animais , Antidepressivos/farmacologia , Comportamento Animal/efeitos dos fármacos , Transtorno Depressivo/tratamento farmacológico , Transtorno Depressivo/etiologia , Transtorno Depressivo/metabolismo , Medicina Tradicional Chinesa/métodos , Redes e Vias Metabólicas/efeitos dos fármacos , Camundongos , Espectroscopia de Prótons por Ressonância Magnética/métodos , Estresse Psicológico/complicações
3.
Zhongguo Zhen Jiu ; 28(6): 409-10, 2008 Jun.
Artigo em Chinês | MEDLINE | ID: mdl-18630536

RESUMO

OBJECTIVE: To find an effective therapy for cardiac neurosis. METHODS: Seventy-two cases were randomly divided into an acupuncture group and a medication group, 36 cases in each group. The acupuncture group were treated with auricular acupuncture combined with body acupuncture, with auricular points Shenmen, Jiaogan (sympathesis), Xin (heart), etc. and body points Xinshu (BL 15), Shenmen (HT 7), Neiguan (PC 6), etc. selected; the medication group were treated with oral administration of Betaloc and Oryzanol. Their therapeutic effects were compared after treatment for 2 months. RESULTS: The cured rate was 77.8% in the acupuncture group and 52.8% in the medication group with very significant differences (P < 0.01), the former being better than the latter. CONCLUSION: Auricular acupuncture combined with body acupuncture is the best method for treatment of cardiac neurosis.


Assuntos
Terapia por Acupuntura , Acupuntura Auricular , Astenia Neurocirculatória/terapia , Adolescente , Adulto , Feminino , Humanos , Masculino , Medicina Tradicional Chinesa , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA